Stay up to date with notifications from The Independent Notifications can be managed in browser preferences. All News Sport Culture Lifestyle The one surprising impact of weight loss jab Ozempic A new Danish study indicates that semaglutide, marketed as Wegovy and Ozempic , may help individuals grappling with alcohol use disorder. The 26-week trial involved 108 obese patients with alcohol use disorder, with half receiving semaglutide and the other half a placebo, alongside talking therapy. Participants administered semaglutide showed a significant reduction in heavy drinking days, decreasing from an average of 17 to five per month, and a substantial drop in overall alcohol consumption. Researchers suggest that semaglutide influences the biological mechanisms underlying addiction, potentially offering a new complementary treatment approach for alcohol use disorder.…